SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 325 filers reported holding SEATTLE GENETICS INC in Q2 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $15,598,000 | +1.6% | 91,797 | -31.0% | 0.07% | -22.9% |
| Q1 2020 | $15,351,000 | -53.9% | 133,048 | -54.4% | 0.10% | -43.9% |
| Q4 2019 | $33,335,000 | +23.3% | 291,747 | -7.8% | 0.17% | +9.6% |
| Q3 2019 | $27,034,000 | +44.1% | 316,560 | +16.8% | 0.16% | +45.8% |
| Q2 2019 | $18,763,000 | -1.7% | 271,103 | +4.0% | 0.11% | -7.8% |
| Q1 2019 | $19,087,000 | +30.7% | 260,606 | +1.1% | 0.12% | +9.4% |
| Q4 2018 | $14,608,000 | -33.0% | 257,810 | -8.8% | 0.11% | -20.3% |
| Q3 2018 | $21,789,000 | +14.1% | 282,538 | -1.7% | 0.13% | +2.3% |
| Q2 2018 | $19,089,000 | -47.3% | 287,531 | -58.5% | 0.13% | -49.2% |
| Q1 2018 | $36,232,000 | +3.0% | 692,242 | +5.3% | 0.26% | +7.1% |
| Q4 2017 | $35,176,000 | -2.8% | 657,498 | -1.2% | 0.24% | -11.8% |
| Q3 2017 | $36,204,000 | +4.7% | 665,390 | -0.5% | 0.27% | +4.2% |
| Q2 2017 | $34,591,000 | -18.3% | 668,546 | +3.6% | 0.26% | -23.8% |
| Q1 2017 | $42,350,000 | +26.1% | 645,080 | +1.4% | 0.34% | +13.7% |
| Q4 2016 | $33,578,000 | -7.1% | 636,302 | -5.0% | 0.30% | -6.2% |
| Q3 2016 | $36,157,000 | +28.5% | 669,458 | -3.8% | 0.32% | +22.1% |
| Q2 2016 | $28,133,000 | +12.5% | 696,200 | -2.3% | 0.26% | +11.5% |
| Q1 2016 | $25,004,000 | -18.3% | 712,572 | +4.5% | 0.24% | -18.1% |
| Q4 2015 | $30,603,000 | +27.0% | 681,900 | +9.1% | 0.29% | +37.3% |
| Q3 2015 | $24,104,000 | -16.7% | 625,120 | +4.6% | 0.21% | +386.0% |
| Q2 2015 | $28,930,000 | +32.2% | 597,728 | -3.4% | 0.04% | +26.5% |
| Q1 2015 | $21,884,000 | +8.4% | 619,086 | -1.5% | 0.03% | +3.0% |
| Q4 2014 | $20,192,000 | -12.0% | 628,452 | +1.9% | 0.03% | -15.4% |
| Q3 2014 | $22,933,000 | -0.6% | 616,829 | +2.3% | 0.04% | +2.6% |
| Q2 2014 | $23,071,000 | -13.3% | 603,182 | +3.3% | 0.04% | -13.6% |
| Q1 2014 | $26,600,000 | +25.3% | 583,852 | +9.7% | 0.04% | +25.7% |
| Q4 2013 | $21,222,000 | -7.5% | 532,021 | +1.7% | 0.04% | -14.6% |
| Q3 2013 | $22,939,000 | +29.1% | 523,367 | -7.4% | 0.04% | +17.1% |
| Q2 2013 | $17,775,000 | – | 565,021 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |